Active, not recruitingNCT05800093
Proteomics and Genomics Combined With CT to Predict CVD
Studying Cold agglutinin disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Principal Investigator
- Erik SG Stroes, MD PhDAmsterdam UMC
- Enrollment
- 310 target
- Eligibility
- 50-75 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Amsterdam UMC, location AMC, Amsterdam, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05800093 on ClinicalTrials.govOther trials for Cold agglutinin disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07552948Radial vs Vena No-Touch AssessmentTomsk Cardiology Research Institute
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07268170Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery DiseaseGødstrup Hospital
- RECRUITINGNANCT07045194Virtue® SAB in the Treatment of Coronary ISR TrialOrchestra BioMed, Inc
- RECRUITINGNANCT07065487Accuracy of Standard and Geometric Pattern-Assisted Digital Scanning for Full-Arch Implant Prosthesis FrameworksMirna ashraf anis heneen
- RECRUITINGNCT07193693Barriers Limiting OCT Penetration in Clinical PracticeConsorzio Futuro in Ricerca
- RECRUITINGNCT07312318AI-Driven Dynamic Prediction of Non-Target Lesion Progression After PCI: A Chinese Multicenter Cohort StudyChina-Japan Friendship Hospital
- RECRUITINGNCT07378137Comparing the Components of Composite Endpoints for Healthcare Providers and PatientsXijing Hospital
- RECRUITINGPHASE4NCT06451198IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary SyndromeShanghai Zhongshan Hospital